Nevro - Stock Price History | NVRO

Historical daily share price chart and data for Nevro since 2022 adjusted for splits. The latest closing stock price for Nevro as of October 03, 2022 is 47.38.
  • The all-time high Nevro stock closing price was 184.34 on December 23, 2020.
  • The Nevro 52-week high stock price is 121.78, which is 157% above the current share price.
  • The Nevro 52-week low stock price is 39.41, which is 16.8% below the current share price.
  • The average Nevro stock price for the last 52 weeks is 67.81.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Nevro Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 137.2119 171.5400 182.1800 81.0700 81.0700 -53.17%
2020 133.7780 118.0100 184.3400 70.2300 173.1000 47.27%
2019 71.3183 36.5500 117.5400 35.5200 117.5400 202.24%
2018 67.6168 69.4600 92.5000 35.4300 38.8900 -43.67%
2017 84.0505 75.1700 99.1900 65.9400 69.0400 -4.98%
2016 75.8518 66.5000 104.9400 48.3400 72.6600 7.63%
2015 49.1422 38.9500 68.3400 36.2600 67.5100 74.58%
2014 31.4879 25.1900 39.3700 25.0000 38.6700 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.649B $0.387B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.711B 20.24
Edwards Lifesciences (EW) United States $51.226B 36.24
Alcon (ALC) Switzerland $28.513B 24.14
STERIS (STE) Ireland $16.630B 20.66
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Globus Medical (GMED) United States $5.928B 30.24
Glaukos (GKOS) United States $2.520B 0.00
Integer Holdings (ITGR) United States $2.061B 16.12
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23